title: Health-related Quality of Life of Individuals With Neurofibromatosis Type 2: Results From the NF2 Natural History Study.
abstract: To explore health-related quality of life (HRQoL) reported by individuals with neurofibromatosis type 2 (NF2) and to assess for correlations between HRQoL and objective measures of disease manifestations.
  
  
  
  Prospective observational study.
  
  
  
  Seven international NF2 centers.
  
  
  
  Eighty-one individuals with NF2, 73 adults (>18 years) and 8 children/adolescents (10-17 years).
  
  
  
  Quality of life was measured by Short Form-36 (SF-36) norm-based scores. Objective clinical measures were hearing (categorized by word-recognition scores), facial function (categorized by the House-Brackmann scale) and the volume of subjects' larger vestibular schwannoma (VS).
  
  
  
  At baseline, adults showed significant deficits in all but two subscales of the SF-36 compared with age- and gender-adjusted United States population norms. In linear regression models including age, gender, inheritance status, hearing, facial weakness and VS volume, demographic and functional measures showed no relationship to any SF-36 subscale. Larger baseline VS volume was significantly related to reduced physical role performance, reduced mental health, and increased pain (p < 0.05). In bivariate analysis, previous VS surgery was not significantly associated with baseline HRQoL; receipt of VS surgery or tumor growth during the observation period was not significantly associated with changes in HRQoL.
  
  
  
  NF2 patients report reduced HRQoL in physical, social, and mental domains, but this was not significantly related to objective measures of hearing or facial functioning. Larger baseline VS volume negatively impacted patient-reported HRQoL whereas VS surgery or tumor growth did not. Future studies should explore the relationship between tumor volume and HRQoL and psychosocial factors that may moderate this relationship.
authors.affiliation: *Department of Neurology and Cancer Center, Massachusetts General Hospital, Boston, Massachusetts †Department of Neurology, Johns Hopkins Hospital, Baltimore, Maryland ‡Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts §Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts ||Department of Neurotology, House Clinic, Los Angeles, California.
authors.forename: Vanessa L
authors.initials: VL
authors.lastname: Merker
authors.forename: Amanda L
authors.initials: AL
authors.lastname: Bergner
authors.forename: Ana-Maria
authors.initials: AM
authors.lastname: Vranceanu
authors.forename: Alona
authors.initials: A
authors.lastname: Muzikansky
authors.forename: William
authors.initials: W
authors.lastname: Slattery
authors.forename: Scott R
authors.initials: SR
authors.lastname: Plotkin
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016518:Neurofibromatosis 2 / Q000150:complications* / Q000523:psychology; D011446:Prospective Studies; D011788:Quality of Life; D055815:Young Adult